Weight status of children with sickle cell disease

Anjulika Chawla1, Philippa G Sprinz, Jennifer Welch

  • 1Division of Pediatric Hematology/Oncology, Warren Alpert Medical School of Brown University/Hasbro Children's Hospital, 593 Eddy St, Providence, RI 02903, USA. achawla@lifespan.org

Pediatrics
|March 6, 2013
PubMed

Insights

Nearly a quarter of children with sickle cell disease (SCD) are overweight or obese. Higher hemoglobin levels correlate with increased weight status in pediatric SCD patients, warranting further research.

Area of Science:

  • Pediatric Hematology
  • Public Health
  • Genetics

Background:

  • Historically, children and adolescents with sickle cell disease (SCD) often presented as underweight.
  • Advances in SCD treatment, such as hydroxyurea, have shown potential for improving growth trajectories.
  • This study investigates the relationship between hemoglobin levels and weight status in pediatric SCD patients.

Purpose of the Study:

  • To test the hypothesis that higher hemoglobin (Hb) levels are associated with increased weight status in children and adolescents with SCD.
  • To determine the prevalence of underweight, overweight, and obesity in a pediatric SCD population in New England.

Main Methods:

  • A retrospective chart review was conducted on 675 patients aged 2-19 years across 6 institutions in New England between 2007-2009.
  • Data collected included height, weight, baseline Hb levels, demographics, and comorbidities.
  • Body Mass Index (BMI) percentiles were used to define underweight (<5th percentile) and overweight/obesity (≥85th/≥95th percentile).

Main Results:

  • In the study sample, 22.4% of children and adolescents with SCD were overweight or obese, while 6.7% were underweight.
  • Overweight/obesity was associated with non-Hb SS or Hb Sβ(0) genotypes and higher baseline Hb levels.
  • Each 1 g/dL increase in baseline Hb levels was associated with a 36% increased odds of being overweight/obese, after adjusting for covariates.

Conclusions:

  • A significant proportion (nearly one-quarter) of children and adolescents with SCD in New England are overweight or obese.
  • Underweight status was linked to male gender, older age, and SCD-related complications.
  • Further longitudinal studies are essential to understand the long-term effects of elevated BMI on morbidity and mortality in individuals with SCD.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...